mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.4 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.4 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |